Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.

The research article delves into how paste formulations of firocoxib and phenylbutazone affect horses with natural osteoarthritis. It found that the overall clinical efficacy of a firocoxib paste was comparable to phenylbutazone.

Study Overview

• The study is positioned as a randomized controlled clinical trial that aimed to compare the effectiveness and safety of paste formulations of firocoxib and phenylbutazone among 253 client-owned horses with naturally occurring osteoarthritis.
• Treatment was administered to the horses over an experimental phase of 14 days, at specific doses for firocoxib and phenylbutazone, given orally once every 24 hours.
• Examinations and evaluations were carried out at the start of the experiment, and on the 7th and 14th days. To measure improvement, researchers looked for a reduction in lameness grade or a combined reduction in scores for a variety of indicators including pain during manipulation or palpation, joint swelling, joint circumference, and range of motion.

Results of the Study

• The study concluded that by day 14, the proportion of horses showing clinical improvement in the group treated with firocoxib was not significantly different from the group treated with phenylbutazone.
• It was, however, observed that more horses treated with firocoxib displayed significant improvements for certain parameters including pain during manipulation or palpation, joint circumference, and range of motion.
• The scores for overall lameness and joint swelling did not significantly differ between the two treatment groups.
• Importantly, the research did not observe any direct, treatment-related adverse effects during the study duration, suggesting that both treatment modes were safe for the osteoarthritis-affected horses.

Conclusion

• By studying the results, it is suggested that the overall clinical efficacy of a paste formulation of firocoxib was comparable with the effectiveness of a paste formulation of phenylbutazone in the treatment of natural osteoarthritis among horses.
• Despite no difference in overall improvement, treatment with firocoxib showed higher effectiveness in alleviating specific symptoms such as pain on manipulation and palpation, joint circumference, and range of motion.
• This implies that while both treatments have overall comparable efficacy in managing osteoarthritis, firocoxib may offer additional benefits for certain symptoms.